Assignee profile
Monte Rosa Therapeutics
Coverage of patents, compounds and activity records linked to this assignee.
14 patents1,264 compounds3,476 activity records
Summary
AssigneeMonte Rosa Therapeutics
Filing years2022-2025
Patents14
Compounds1,264
Activity records3,476
Patent families14
Targets10
Assay familiesbinding, biochemical, cellular_function, degradation, unknown
Activity metricsDC50, Dmax, EC50, IC50, Ki, degradation
Overview
Target distribution and active-compound trend
Target distribution
3,508 activity records
Active compounds by publication year
Distinct compounds linked to assignee patent publications
Activity compounds and values